Fachrepositorium Lebenswissenschaften

12 Treffer

Seiten

Suche

Publisso-Menue

Seiten

Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer

2024 . Uhlenbruch, Mark | Krüger, Stefan

Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies

2024 . Gorgulho, João | Roderburg, Christoph | Beier, Fabian | Bokemeyer, Carsten | Brümmendorf, Tim | Loosen, Sven H. | Luedde, Tom

Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection

2024 . Wasilewski, David | Onken, Julia | Höricke, Paul | Bukatz, Jan | Murad, Selin | Früh, Anton | Shaked, Zoe | Misch, Martin | Kühl, Anja | Klein, Oliver | Ehret, Felix | Kaul, David | Radbruch, Helena | Capper, David | Vajkoczy, Peter | Horst, David | Frost, Nikolaj | Bischoff, Philip

Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients

2021 . Purde, Mette-Triin | Niederer, Rebekka | Wagner, Nikolaus B. | Diem, Stefan | Berner, Fiamma | Hasan Ali, Omar | Hillmann, Dorothea | Bergamin, Irina | Joerger, Markus | Risch, Martin | Niederhauser, Christoph | Lenz, Tobias L. | Früh, Martin | Risch, Lorenz | Semela, David | Flatz, Lukas

Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC

2021 . Weber, Daniel | Decker, Miriam | Schuster, Michael | Folz, Sara | Stürmer, Carsten Johannes | Lutz, Manfred

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

2021 . Unterrainer, Marcus | Taugner, Julian | Käsmann, Lukas | Tufman, Amanda | Reinmuth, Niels | Li, Minglun | Mittlmeier, Lena M. | Bartenstein, Peter | Kunz, Wolfgang G. | Ricke, Jens | Belka, Claus | Eze, Chukwuka | Manapov, Farkhad

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

2021 . Taugner, Julian | Käsmann, Lukas | Karin, Monika | Eze, Chukwuka | Flörsch, Benedikt | Guggenberger, Julian | Li, Minglun | Tufman, Amanda | Reinmuth, Niels | Duell, Thomas | Belka, Claus | Manapov, Farkhad

Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial

2021 . Christopoulos, Petros | Bozorgmehr, Farastuk | Brückner, Lena | Chung, Inn | Krisam, Johannes | Schneider, Marc A. | Stenzinger, Albrecht | Eickhoff, Regina | Mueller, Daniel W. | Thomas, Michael

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil

2021 . Eichkorn, Tanja | Schunn, Fabian | Regnery, Sebastian | Shafie, Rami El | Hörner-Rieber, Juliane | Adeberg, Sebastian | Herfarth, Klaus | Debus, Jürgen | König, Laila

First-line anti-VEGF plus EGFR-TKI in EGFR-mutant NSCLC: adding the ARTEMIS trial to the puzzle of current evidence

2021 . Hafner, Susanne

Seiten